Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Sarcoma 1Neoplasms 1Muscle Neoplasms 1HIV Infections 1Acquired Immunodeficiency Syndrome 1AIDS-Related Complex 1

Interventions

Doxorubicin 5Filgrastim 4Zidovudine 3Vincristine 3Etoposide 3Valganciclovir 2Thalidomide 2Rituximab 2Mitoxantrone 2Interferon alpha-2 2Cyclophosphamide 2Bleomycin 2ziconotide 1vesnarinone 1tocilizumab 1tin etiopurpurin 1interferon gamma-1b 1human papillomavirus vaccine, L1 type 16, 18 1Vinblastine 1Tumor Necrosis Factor-alpha 1Sugars 1Semaxinib 1Ro 24-7429 1Ritonavir 1Prednisone 1Paclitaxel 1Nivolumab 1Mitoguazone 1Methotrexate 1Medical Marijuana 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Acquired Immunodeficiency Syndrome × Tumor Necrosis Factor-alpha × Clear all
NCT00001004 2021-11-04

A Study of Tumor Necrosis Factor and Human Interferon-gamma in Patients With AIDS Related Complex

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 2 Completed
30 enrolled

Acquired Immunodeficiency Syndrome, AIDS-Related Complex, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡